Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human CD37 Reference Antibody (Ivicentamab, RUO) (HY564046)

Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HY564046
説明
Ivicentamab (HY564046) is a research-grade recombinant antibody targeting CD37. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプIgG1-kappa
発現システム Mammalian cells
テスト済みアプリケーション WB, FCM
ターゲット CD37, Tspan-26, TSPAN26, Leukocyte antigen CD37, Tetraspanin-26
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P11049
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名DuoHexaBody-CD37, GEN3009, GEN-3009, GEN30092364496-42-2
背景

Leukocyte antigen CD37 (TSPAN26) is a ~31 kDa protein. Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling. Participates thereby in diverse biological functions such as cell signal transduction, adhesion, migration and protein trafficking. Upon ligand binding, two signaling pathways are activated, one acting through phosphorylation by LYN leading to cell death or a survival pathway with activation of GSK3B. Plays an essential role essential for clustering of integrin ITGA4/ITGB1 and promotes its mobility in the plasma membrane of B-cells. In turn, participates in ITGA4/ITGB1 integrin-mediated antiapoptotic signaling through AKT.

1. Lapalombella, R. et al. (2012) Cancer cell 21, 694-708. PMID: 22624718
2. de Winde, CM. et al. (2016) The Journal of clinical investigation 126, 653-66. PMID: 26784544
3. Meyer-Wentrup, F. et al. (2007) Journal of immunology (Baltimore, Md. : 1950) 178, 154-62. PMID: 17182550
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
イメージ
  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Ivicentamab.

  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Ivicentamab.

  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    Flow CytoMetry

    Flow-cytometry using APC anti-human CD37 antibody. Raji cells were stained with an irrelevant antibody (Blue Histogram) or an APC anti-human CD37 monoclonal antibody (Catalog: HY564046, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    Flow CytoMetry

    Flow-cytometry using FITC anti-human CD37 antibody. Raji cells were stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human CD37 monoclonal antibody (Catalog: HY564046, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    Flow CytoMetry

    Flow-cytometry using PE anti-human CD37 antibody. Raji cells were stained with an irrelevant antibody (Blue Histogram) or an PE anti-human CD37 monoclonal antibody (Catalog: HY564046, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD37 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD37 (Catalog No: HY564012)
    Lane 2: negative control

  • Anti-Human CD37 Reference Antibody (Ivicentamab, RUO)

    Bioactivity

    Detects recombinant human CD37 (Catalog No: HY564012) in indirect ELISA

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト